PetCaseFinder

Peer-reviewed veterinary case report

Echocardiography predicts outcomes in dogs with mitral valve disease

By Osuga, Tatsuyuki et al.·Published in Journal of veterinary internal medicine·2021·Veterinary Teaching Hospital, Japan·View original on PubMed

PetCaseFinder translated the abstract of this peer-reviewed paper into plain English so pet owners can read it. We do not publish original research — every detail traces back to the citation above. How we work →

Original publication title: Prognostic value of left ventricular-arterial coupling estimated using echocardiography in dogs with myxomatous mitral valve disease.

Species:
dog

Plain-English summary

A group of 89 dogs with myxomatous mitral valve disease (MMVD), a common heart issue in older dogs, was studied to see how heart function affects survival. The researchers found that dogs with a specific measurement indicating poor heart and artery interaction had a significantly shorter lifespan compared to those with healthier measurements. Specifically, dogs with a higher ratio of arterial load to heart function had a median survival time of about 527 days, while those with a healthier ratio lived over 1,112 days. This suggests that monitoring these heart function indicators can help predict outcomes in dogs with MMVD.

People also search for: dog heart disease prognosis · myxomatous mitral valve disease in dogs · echocardiogram results for dogs · how long can a dog live with heart disease

Abstract

BACKGROUND: The interaction between the left ventricle (LV) and systemic arterial systems, known as left ventricular-arterial coupling (VAC), has been evaluated based on the effective arterial elastance (Ea) to LV end-systolic elastance (Ees) ratio (Ea/Ees). The Ea reflects the total arterial load of LV, whereas Ees reflects the LV systolic function. A recent study found that inappropriate VAC based on increased Ea/Ees estimated by echocardiography is associated with advanced disease severity in dogs with myxomatous mitral valve disease (MMVD). HYPOTHESIS: Inappropriate VAC assessed by echocardiographic estimation of Ea/Ees is associated with a worse prognosis in dogs with MMVD. ANIMALS: Eighty-nine dogs with MMVD. METHODS: Prospective cohort study. Dogs underwent echocardiographic examinations at enrollment. The Ea was estimated using the formula: mean blood pressure/(forward stroke volume/body weight). The Ees was estimated using the formula: mean blood pressure/(LV end-systolic volume/body weight). The Ea/Ees was calculated. RESULTS: By end of study, 22 dogs died of cardiac-related causes with 67 dogs censored. Dogs with increased Ea/Ees (Ea/Ees >0.34; median survival time, 527&#x2009;days; 95% confidence interval [CI], 322&#x2009;days-not determinable) had a shorter survival time (P&#x2009;<&#x2009;.0001) than those without increased Ea/Ees (Ea/Ees &#x2264;0.34; median survival time, >1112&#x2009;days; 95% CI, not determinable). Multivariate Cox proportional hazard analysis showed that Ea/Ees, body weight, peak systolic mitral annular velocity, and the peak early diastolic transmitral velocity-to-peak early diastolic mitral annular velocity ratio were independent predictors of cardiac-related death among echocardiographic indices. CONCLUSIONS AND CLINICAL IMPORTANCE: Inappropriate VAC assessed based on echocardiographically-estimated Ea/Ees is associated with a worse prognosis in dogs with MMVD.

Find similar cases for your pet

PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.

Search related cases →

Original publication on PubMed: https://pubmed.ncbi.nlm.nih.gov/34741477/